Published in Prev Sci on June 01, 2010
Socioecological influences on community involvement in HIV vaccine research. Vaccine (2011) 1.05
Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south. Vaccine (2012) 1.03
Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation. Open Access J Clin Trials (2010) 0.90
Delivering a "dose of hope": a faith-based program to increase older african americans' participation in clinical trials. JMIR Res Protoc (2015) 0.83
Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand. PLoS One (2014) 0.82
Neighborhood Influences on Seasonal Influenza Vaccination among Older African Americans in Atlanta, Georgia. J Immunol Tech Infect Dis (2016) 0.76
Factors associated with seasonal influenza immunization among church-going older African Americans. Vaccine (2014) 0.75
Results of a Community Randomized Study of a Faith-Based Education Program to Improve Clinical Trial Participation among African Americans. Int J Environ Res Public Health (2015) 0.75
The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania. PLoS One (2016) 0.75
Psychological distress, health protection, and sexual practices among young men who have sex with men: Using social action theory to guide HIV prevention efforts. PLoS One (2017) 0.75
The role of functional, social, and mobility dynamics in facilitating older African Americans participation in clinical research. Open Access J Clin Trials (2017) 0.75
Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med (1999) 11.58
A venue-based method for sampling hard-to-reach populations. Public Health Rep (2001) 6.43
Theories of reasoned action and planned behavior as models of condom use: a meta-analysis. Psychol Bull (2001) 5.82
Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med (2002) 5.52
Subpopulation estimates from the HIV incidence surveillance system--United States, 2006. MMWR Morb Mortal Wkly Rep (2008) 4.68
Male circumcision for HIV prevention: from evidence to action? AIDS (2008) 4.11
HIV vaccine research: the way forward. Science (2008) 3.86
Ethics in public health research: protecting human subjects: the role of community advisory boards. Am J Public Health (2004) 3.08
HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr (2006) 2.35
The urgent need for a vaginal microbicide in the prevention of HIV transmission. Am J Public Health (1994) 2.03
Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US. Int J STD AIDS (2006) 2.02
High-risk sexual behavior and condom use among gay and bisexual African-American men. Am J Public Health (1992) 2.00
HIV/AIDS: a minority health issue. Med Clin North Am (2005) 1.96
Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA (2006) 1.90
Towards a science of community engagement. Lancet (2006) 1.88
The cognitive impact of past behavior: influences on beliefs, attitudes, and future behavioral decisions. J Pers Soc Psychol (2000) 1.88
Perceptions of clinical research participation among African American women. J Womens Health (Larchmt) (2007) 1.86
Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr (2001) 1.66
Rapid HIV testing in outreach and other community settings--United States, 2004-2006. MMWR Morb Mortal Wkly Rep (2007) 1.57
African Americans and participation in clinical trials: differences in beliefs and attitudes by gender. Contemp Clin Trials (2006) 1.51
HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Vaccine (2005) 1.50
Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City. J Urban Health (2000) 1.47
Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr (2001) 1.43
AIDS/HIV. A STEP into darkness or light? Science (2008) 1.39
Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. J Acquir Immune Defic Syndr (2005) 1.35
Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. J Acquir Immune Defic Syndr (2000) 1.33
Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy. J Int Assoc Physicians AIDS Care (Chic) (2003) 1.27
Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002. Public Health Rep (2005) 1.22
Microbicides in HIV prevention. BMJ (2001) 1.12
The influence of religion on organ donation and transplantation among the Black Caribbean and Black African population--a pilot study in the United Kingdom. Ethn Dis (2006) 1.10
Factors associated with the acceptance of an AIDS vaccine: an exploratory study. Prev Med (2004) 1.09
Negative social impacts among volunteers in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr (2007) 1.05
HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion. J Natl Med Assoc (2005) 1.05
Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents. AIDS Behav (2007) 0.99
Applying the Theory of Reasoned Action to condom use among sex workers. Soc Behav Pers (1998) 0.99
Predictors of sexual risk behaviors among adolescent mothers in a human immunodeficiency virus prevention program. J Adolesc Health (2006) 0.97
Factors influencing HIV vaccine community engagement in the urban South. J Community Health (2008) 0.96
Scientific and policy challenges to development of an AIDS vaccine. Lancet (2007) 0.94
Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement? Challenge (Atlanta Ga) (2007) 0.93
Issues related to gay and bisexual men's acceptance of a future AIDS vaccine. Int J STD AIDS (2005) 0.93
Behavioral aspects of clinical trials. An integrated framework from behavior theory. Cancer (1994) 0.93
Identifying the motivations of African American volunteers working to prevent HIV/AIDS. AIDS Educ Prev (2001) 0.89
Acceptance of a potential HIV/AIDS vaccine among minority women. J Natl Med Assoc (2008) 0.89
Correlates of negative intent to receive an AIDS vaccine: an exploratory study. Int J STD AIDS (2004) 0.89
Women who put condoms on male partners: correlates of condom application. Am J Health Behav (2006) 0.89
Recent efforts in biomedical prevention of HIV. Top HIV Med (2007) 0.89
A brief history of HIV vaccine research: stepping back to the drawing board? AIDS (2008) 0.88
The role of physician characteristics in clinical trial acceptance: testing pathways of influence. J Health Commun (2006) 0.88
Young adults and HIV vaccine: determinants of the intention of getting immunized. Can J Public Health (2001) 0.87
Is participation in HIV vaccine trials a health promoting behaviour? AIDS Care (2007) 0.85
Recommendations of the clinical trials consensus panel. National Medical Association. J Natl Med Assoc (2000) 0.82
Predicting intention to use condoms in homosexual men: an application and extension of the theory of reasoned action. Psychol Health (1996) 0.80
Ethical considerations in AIDS vaccine testing. IRB (1989) 0.77
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med (2011) 7.29
Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS (2005) 5.43
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity (2008) 5.22
Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol (2002) 4.65
AIDS in Mexico: lessons learned and implications for developing countries. AIDS (2002) 4.48
Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis (2012) 3.42
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med (2013) 3.24
The inevitability of infidelity: sexual reputation, social geographies, and marital HIV risk in rural Mexico. Am J Public Health (2007) 3.03
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol (2009) 2.68
Understanding the patient's perspective on rapid and routine HIV testing in an inner-city urgent care center. AIDS Educ Prev (2004) 2.45
It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis (2005) 2.40
Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061. PLoS One (2013) 2.32
Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis (2008) 2.14
Reasons for not HIV testing, testing intentions, and potential use of an over-the-counter rapid HIV test in an internet sample of men who have sex with men who have never tested for HIV. Sex Transm Dis (2011) 1.92
Social discrimination and resiliency are not associated with differences in prevalent HIV infection in black and white men who have sex with men. J Acquir Immune Defic Syndr (2014) 1.90
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis (2012) 1.80
Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol (2009) 1.77
A case-based, problem-based learning approach to prepare master of public health candidates for the complexities of global health. Am J Public Health (2015) 1.73
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. J Acquir Immune Defic Syndr (2007) 1.73
The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr (2006) 1.71
Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acquir Immune Defic Syndr (2007) 1.71
Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications. J Infect Dis (2005) 1.69
Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med (2007) 1.69
Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis (2013) 1.64
Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res Hum Retroviruses (2004) 1.58
Clinical, epidemiologic characteristics of foreign-born Latinos with HIV/AIDS at an urban HIV clinic. AIDS Read (2007) 1.55
Impact of public housing relocations: are changes in neighborhood conditions related to STIs among relocaters? Sex Transm Dis (2014) 1.54
Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read (2002) 1.51
Spatial clustering of HIV prevalence in Atlanta, Georgia and population characteristics associated with case concentrations. J Urban Health (2011) 1.48
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1. AIDS Res Hum Retroviruses (2007) 1.46
Potential for medical transmission of HIV in Ethiopia. AIDS (2005) 1.39
Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug Alcohol Depend (2006) 1.38
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults. AIDS Res Hum Retroviruses (2009) 1.36
Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis (2005) 1.35
Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis (2012) 1.34
Emphysematous cholecystitis due to Salmonella derby. Lancet Infect Dis (2006) 1.29
Health literacy is a predictor of HIV/AIDS knowledge. Fam Med (2006) 1.29
Low health literacy is associated with HIV test acceptance. J Gen Intern Med (2005) 1.28
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Ann Intern Med (2013) 1.27
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens. J Infect Dis (2010) 1.26
CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS (2005) 1.26
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS (2002) 1.24
Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US. Eur J Epidemiol (2006) 1.23
Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med (2009) 1.20
Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. Am J Public Health (2004) 1.20
Demographic, psychological, and behavioral modifiers of the Antiretroviral Treatment Access Study (ARTAS) intervention. AIDS Patient Care STDS (2009) 1.20
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. J Infect Dis (2004) 1.20
Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol (2002) 1.19
Global noncommunicable diseases--lessons from the HIV-AIDS experience. N Engl J Med (2011) 1.14
Monitoring HIV treatment in developing countries. BMJ (2006) 1.13
High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis (2008) 1.13
Depressive symptoms and food insufficiency among HIV-infected crack users in Atlanta and Miami. AIDS Behav (2011) 1.13
Food insufficiency among HIV-infected crack-cocaine users in Atlanta and Miami. Public Health Nutr (2010) 1.12
Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. J Acquir Immune Defic Syndr (2003) 1.10
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis (2011) 1.08
Addressing the challenges of the HIV continuum of care in high-prevalence cities in the United States. J Acquir Immune Defic Syndr (2015) 1.06
A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity. Am J Trop Med Hyg (2012) 1.06
Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. Am J Public Health (2009) 1.05
The emerging HIV/AIDS epidemic in Georgia. Int J STD AIDS (2005) 1.05
Socioecological influences on community involvement in HIV vaccine research. Vaccine (2011) 1.05
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth. Antivir Ther (2012) 1.03
Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south. Vaccine (2012) 1.03
Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods. AIDS Res Hum Retroviruses (2011) 1.03
Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors. Clin Infect Dis (2009) 1.02
Acceptance of pandemic 2009 influenza A (H1N1) vaccine in a minority population: determinants and potential points of intervention. Pediatrics (2011) 1.02
Psychological and behavioral correlates of entering care for HIV infection: the Antiretroviral Treatment Access Study (ARTAS). AIDS Patient Care STDS (2007) 1.01
Rapid HIV testing: a review of the literature and implications for the clinician. Curr HIV/AIDS Rep (2006) 1.01
Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care. J Acquir Immune Defic Syndr (2010) 0.97
Swine-origin influenza A (H1N1) and HIV. The CDC offers guidance for HIV-infected patients potentially exposed to swine flu. J Watch AIDS Clin Care (2009) 0.97
The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales. J Clin Epidemiol (2010) 0.96
Factors influencing HIV vaccine community engagement in the urban South. J Community Health (2008) 0.96
Risk factors for hepatitis C virus infection among blood donors in Georgia. Eur J Epidemiol (2004) 0.95
Genetic diversity of Pneumocystis carinii f. sp. hominis based on variations in nucleotide sequences of internal transcribed spacers of rRNA genes. J Clin Microbiol (2002) 0.95
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood. Emerg Infect Dis (2017) 0.95
Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect Dis (2012) 0.95
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. J Acquir Immune Defic Syndr (2015) 0.94
Latinos and HIV care in the Southeastern United States: new challenges complicating longstanding problems. Clin Infect Dis (2011) 0.94
Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial. J Acquir Immune Defic Syndr (2009) 0.94
Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement? Challenge (Atlanta Ga) (2007) 0.93
Foamy virus envelope glycoprotein is sufficient for particle budding and release. J Virol (2003) 0.93
Correlates of HIV risk and preventive behaviors in Armenian female sex workers. AIDS Behav (2007) 0.93
HIV/AIDS complacency and HIV infection among young men who have sex with men, and the race-specific influence of underlying HAART beliefs. Sex Transm Dis (2011) 0.92
Commentary: IDSA guidelines for improving the teaching of preclinical medical microbiology and infectious diseases. Acad Med (2010) 0.90
Imported malaria at an inner-city hospital in the United States. Am J Med Sci (2005) 0.90
Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation. Open Access J Clin Trials (2010) 0.90